Premium
Cinclus Pharma signs billion-dollar deal with Zentiva
Cinclus Pharma has signed a license agreement with Zentiva for the commercialization and manufacturing of linaprazan glurate in Europe, worth the equivalent of...
Drug tariffs could increase costs by $51 billion
A new report warns that an American...
AstraZeneca in new AI investment
AstraZeneca has signed an agreement with Tempus and...
Extensive study points to cannabis' potential in cancer
A large-scale meta-analysis shows clear support for...
Eli Lilly's oral weight loss drug impresses in Phase III
Orforglipron, a new daily tablet for the treatment of...
The pharmaceutical industry's call to the EU: Act!
A large number of global pharmaceutical giants are threatening to move...
J&J: Tax policy better than tariffs for US drug manufacturing
Johnson & Johnson kicked off the reporting season in...
New executive order to lower drug prices
The US President is reinstating several measures from his...
Pfizer throws in the towel in the obesity race
Pfizer has suspended development of the oral obesity drug...
Pharmaceutical tariffs expected within two months
The US is preparing to impose extensive tariffs...
FDA wants to phase out animal testing
The US Food and Drug Administration (FDA) has announced a plan...
European pharmaceutical companies warn of capital flight to the US
Several of Europe's leading pharmaceutical companies are now sounding the alarm...
Notes
Hansa Biopharma appoints new CMO
Perpetua Medical sells assets for SEK 10 million
Lipum reaches 89 percent subscription of warrants
EQL Pharma expands to Germany and the Netherlands
Oncopeptides Pepaxti included in European treatment guidelines
NEWSLETTER
NEWS
In the shadow of the GLP-1 hype: new report criticizes pharmaceutical companies' patent strategies
Five Nordic biotech stock market winners in H1 2025
Chugai and Gero in billion-dollar deal within AI
Upcoming events!
Investing in Life Science
Discover unparalleled opportunities, set in the vibrant heart of Stockholm. This premier event unites forward-thinking investors and business leaders to...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles
The EU's new life science strategy – a step in the right direction or just fluff?
Early signs of spring in an otherwise frosty biotech landscape
